Document:

WWW.EXFILE.COM, INC. -- 888-775-4789 -- PERFORMANCE HEALTH TECHNOLOGIES, INC. -- EXHIBIT 10.114 TO FORM 10-KSB

    EXHIBIT
10.114

     

    THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED OR DISPOSED OF
EXCEPT PURSUANT TO (1) A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED
EFFECTIVE UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY
APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR (2) UPON
DELIVERY OF A LEGAL OPINION TO THE COMPANY, IN FORM AND SUBSTANCE REASONABLY
SATISFACTORY TO THE COMPANY, THAT ANY SUCH TRANSACTION IS EXEMPT FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS.

    

     Dated:
_____________, 2008

    

    FORM OF WARRANT

    

    To
Purchase _____ shares of

    Common
Stock, $.01 par value

    

    of

    

    Performance
Health Technologies, Inc.

    

    Expiring
________________, 2013

    

    THIS IS
TO CERTIFY THAT, for value received, _______________________________, or his registered
assigns (hereinafter referred to as the (“Holder”), is entitled
to subscribe and purchase from PERFORMANCE HEALTH TECHNOLOGIES,
INC., a Delaware corporation (the “Company”), commencing
on the date hereof, _________ shares of Common Stock, $.01 par value, of the
Company (the “Shares”), at the
place where the Warrant Agency (as hereinafter defined) is located, at the
Exercise Price (as hereinafter defined), all subject to adjustment and upon the
terms and conditions as hereinafter provided, and is entitled also to exercise
the other appurtenant rights, powers and privileges hereinafter described;
provided, however, that in no event shall the Holder be entitled to exercise
this Warrant for a number of Shares in excess of that number of Shares which,
upon giving effect to such exercise, would cause the aggregate number of shares
of Company Common Stock beneficially owned by the Holder and its affiliates to
exceed 9.99% of the outstanding shares of the Company Common Stock following
such exercise, except within sixty (60) days of the Expiration
Date.  For purposes of the foregoing proviso, the aggregate number of
shares of Common Stock beneficially owned by the Holder and its affiliates shall
include the number of shares of Common Stock issuable upon exercise of this
Warrant with respect to which the determination of such proviso is being made,
but shall exclude shares of Common Stock which would be issuable upon
(i) exercise of the remaining, unexercised Warrants beneficially owned by
the holder and its affiliates and (ii) exercise or conversion of the
unexercised or unconverted portion of any

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    other
securities of the Company beneficially owned by the holder and its affiliates
(including, without limitation, any convertible notes or preferred stock)
subject to a limitation on conversion or exercise analogous to the limitation
contained herein.  Except as set forth in the preceding sentence, for
purposes of this paragraph, beneficial ownership shall be calculated in
accordance with Section 13(d) of the Securities Exchange Act of 1934, as
amended.  For purposes of this Warrant, in determining the number of
outstanding shares of Common Stock a Holder may rely on the number of
outstanding shares of Common Stock as reflected in (1) the Company’s most recent
Form 10-QSB or Form 10-KSB, as the case may be, (2) a more recent public
announcement by the Company or (3) any other notice by the Company or its
transfer agent setting forth the number of shares of Common Stock
outstanding.  Upon the written request of any holder, the Company
shall promptly, but in no event later than one (1) Business Day following the
receipt of such notice, confirm in writing to any such holder the number of
shares of Common Stock then outstanding.  In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to
the exercise of Warrants (as defined below) by such holder and its affiliates
since the date as of which such number of outstanding shares of Common Stock was
reported.

     

    Capitalized
terms used in this Warrant and not otherwise defined shall have the meanings set
forth in Article IV hereof.

     

    

    ARTICLE
I

    EXERCISE
OF WARRANTS

    

    Section
1.01                                Method of
Exercise.  To exercise this Warrant in whole or in part, the
Holder shall deliver to the Company at the Warrant Agency, (a) this Warrant, (b)
a written notice, in substantially the form of the Subscription Notice attached
hereto, of such Holder's election to exercise this Warrant, which notice shall
specify the number of Shares to be purchased, the denominations of the share
certificate or certificates desired and the name or names in which such
certificates are to be registered and (c) the aggregate Exercise Price for
the Shares purchased (unless the Holder chooses the "cashless exercise" option
provided in the third paragraph of this Section 1.01).

    

    The
Company shall, as promptly as practicable and in any event within seventy-two
hours thereafter, execute and deliver or cause to be executed and delivered, in
accordance with such notice, a certificate or certificates representing the
aggregate number of Shares specified in said notice.  The Share
certificate or certificates so delivered shall be in such denominations as
determined by the Company, or as may be specified in such notice, and shall be
issued in the name of the Holder or such other name or names as shall be
designated in such notice.  Such certificate or certificates shall be
deemed to have been issued, and such Holder or any other person so designated to
be named therein shall be deemed for all purposes to have become holders of
record of such Shares, as of the date the aforementioned notice is received by
the Company.  If this Warrant shall have been exercised only in part,
the Company shall, at the time of delivery of the certificate or certificates,
deliver to the Holder a new Warrant evidencing the rights to purchase the
remaining Shares called for by this Warrant, which new Warrant shall in all
other respects be identical with this Warrant, or, at the request of the Holder,
appropriate notation may be made on this Warrant which shall then be returned to
the Holder.  The Company shall pay all expenses, payable in connection
with the preparation, issuance and delivery of Share

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    certificates
and new Warrants as contemplated by Section 2.07 below (other than transfer,
income or similar taxes in connection with the transfer of securities), except
that, if Share certificates or new Warrants shall be registered in a name or
names other than the name of the Holder, funds sufficient to pay all transfer
taxes payable as a result of such transfer shall be paid by the Holder at the
time of delivering the aforementioned notice of exercise or promptly upon
receipt of a written request of the Company for payment.

    

    In lieu
of a monetary payment of the aggregate Exercise Price, the Holder may elect to
receive, without the payment of any additional consideration, Shares equal to
the value of this Warrant or portion thereof by the surrender of such Warrant to
the Company with the "cashless exercise" election marked in the form of
Subscription Notice.  Thereupon, the Company shall issue to the
Holder, such number of fully paid and non-assessable Shares as is computed using
the following formula:

     

    
       

     

    
      	
              X =  Y(A-B) 

            	 
	
              A 

            	 

    

     

    
      	
              Where

            	
              X=

            	
              the
      number of Shares to be issued to the Holder pursuant to this Section
      1.01  upon such cashless exercise
  election.

            

    

    

    
      	
               
      

            	
              Y=

            	
              the
      number of Shares covered by this Warrant in respect of which the cashless
      exercise election is made.

            

    

    

    
      	
               
      

            	
              A=

            	
              the
      Fair Market Value (as defined in Article IV hereof) of one Share, as at
      the time the cashless exercise election is
made.

            

    

    

    
      	
               
      

            	
              B=

            	
              the
      Exercise Price in effect under this Warrant at the time the cashless
      exercise election is made.

            

    

    

    Section
1.02                                Shares To Be Fully Paid and
Non-assessable.  All Shares issued upon the exercise of this
Warrant (the "Warrant
Shares") pursuant to Section 1.01 above shall be validly issued, fully
paid and nonassessable and the Company shall at all times reserve and keep
available out of its authorized shares of Common Stock a sufficient number of
Shares for the purpose of issuance of the Warrant Shares upon the exercise of
this Warrant.

    

    Section
1.03                                No Fractional Shares To Be
Issued.  The Company shall not be required to issue fractions
of Shares upon exercise of this Warrant.  If any fraction of a Share
would, but for this Section, be issuable upon any exercise of this Warrant, in
lieu of such fractional Share the Company shall pay to the Holder or Holders, as
the case may be, in cash, an amount equal to the same fraction of the Fair
Market Value per share of outstanding Shares on the Business Day immediately
prior to the date of such exercise.

    

    Section
1.04                                Share
Legend.  Each certificate for Shares issued upon exercise of
this Warrant shall bear the legend set forth below, unless Holder's Counsel (as
defined below) shall render an opinion in form and substance reasonably
satisfactory to the Company that such legend is not required or at the time of
exercise such Shares are registered under the Securities Act:

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND MAY NOT BE
OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT
TO (1) A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE
SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS
OF ANY STATE OF THE UNITED STATES OR (2) UPON DELIVERY OF A LEGAL OPINION TO THE
COMPANY, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, THAT ANY
SUCH TRANSACTION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

    

    Any
certificate issued at any time in exchange or substitution for any certificate
bearing such legend (except a new certificate issued upon completion of a public
distribution pursuant to a registration statement under the Securities Act)
shall also bear such legend unless, in the opinion (in form and substance
reasonably satisfactory to the Company) of counsel selected by the Holder of
such certificate and who is reasonably acceptable to the Company ("Holder's Counsel"),
the securities represented thereby need no longer be subject to restrictions on
resale under the Securities Act.

    

    ARTICLE
II

    WARRANT
AGENCY; TRANSFER,

    EXCHANGE
AND REPLACEMENT OF WARRANTS

    

    Section
2.01                                Warrant
Agency.  Until such time, if any, as an independent agency
shall be appointed by the Company to perform services with respect to the
Warrants described herein (the "Warrant Agency"), the
Company shall perform the obligations of the Warrant Agency provided herein at
its principal office address or such other address as the Company shall specify
by prior written notice to all Holders.

    

    Section
2.02                                Ownership of
Warrant.  The Company may deem and treat the person in whose
name this Warrant is registered as the holder and owner hereof (notwithstanding
any notations of ownership or writing hereon made by any person other than the
Company) for all purposes and shall not be affected by any notice to the
contrary, until presentation of this Warrant for registration of transfer as
provided in this Article II.

    

    Section
2.03                                Transfer of
Warrant.  The Company agrees to maintain at the Warrant Agency
books for the registration of transfers of this Warrant and all rights hereunder
shall be registered, in whole or in part, on such books, upon surrender of this
Warrant at the Warrant Agency, together with a written assignment of this
Warrant duly executed by the Holder or its duly authorized agent or
attorney.  Subject to applicable law and regulation and
Section 2.04 hereof, upon surrender of this Warrant as provided for herein,
the Company shall execute and deliver a new Warrant or Warrants in the name of
the assignee or assignees and in the denominations specified in the instrument
of assignment, and this Warrant shall promptly be 

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    canceled.  Notwithstanding
the foregoing, a Warrant may be exercised by a new Holder which has become the
registered Holder of such Warrant without having a new Warrant
issued.

    

    Section
2.04                                Restrictions on
Transfer.  The Holder, by its acceptance hereof, represents
that this Warrant is being acquired for its own account, as an investment and
not with a view towards the further resale or the distribution thereof in
violation of the Securities Act, and agrees that this Warrant may not be
transferred, sold, assigned, hypothecated or otherwise disposed of, in whole or
in part, except as provided in the legend on the first page hereof and provided
that the Holder shall have furnished to the Company an opinion of Holder's
Counsel, in form and substance reasonably satisfactory to the Company, to the
effect that such transfer is exempt from the registration requirements of the
Securities Act and any applicable state securities laws.

    

    Section
2.05                                Division or Combination of
Warrants.  This Warrant may be divided or combined with other
Warrants upon surrender hereof and of any Warrant or Warrants with which this
Warrant is to be combined at the Warrant Agency, together with a written notice
specifying the names and denominations in which the new Warrant or Warrants are
to be issued, signed by the holders hereof and thereof or their respective duly
authorized agents or attorneys.  Subject to compliance with Section
2.04 as to any transfer which may be involved in the division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for
the Warrant or Warrants to be divided or combined in accordance with such
notice.

    

    Section
2.06                                Loss, Theft, Destruction of
Warrant Certificates.  Upon receipt by the Company of a written
notice (or other evidence reasonably satisfactory to the Company) of the loss,
theft, destruction or mutilation of any Warrant and, in the case of any such
loss, theft or destruction, upon receipt of indemnity or security reasonably
satisfactory to the Company or, in the case of any such mutilation, upon
surrender and cancellation of such Warrant, the Company will make and deliver,
in lieu of such lost, stolen, destroyed or mutilated Warrant, a new Warrant of
like tenor and representing the right to purchase the same aggregate number of
Shares.

    

    Section
2.07                                Expenses of Delivery of
Warrants.  The Company shall pay all expenses (other than
transfer taxes) and other charges payable in connection with the preparation,
issuance and delivery of Warrants and Warrant Shares hereunder.

     

    

    ARTICLE
III

    COMPANY
COVENANTS AND REPRESENTATIONS

    

    Section
3.01                                Company
Covenants.  In case at any time the Company shall
(a) declare any dividend or distribution on its Shares, whether payable in
cash, stock or other property, (b) offer to all holders of Shares any
additional shares of Common Stock, or any option, right or warrant to subscribe
therefore, or (c) declare a dissolution, liquidation or winding up of the
Company (other than in connection with a consolidation or merger) or propose a
sale of substantially all of its property, assets and business as an entirety,
then the Company shall give written notice to the Holder of the date on which
the books of the Company shall close or a record shall be taken for such
action.  Such notice shall also specify the date as of which the
holders of Shares of record shall participate in such dividend or
distribution.  Such written notice shall be given at least 30 days and
not more than 90 days prior to the action in question, and not

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    less than
15 days prior to the relevant record date or the date fixed for determining
stockholders entitled to participate therein, as the case may be.

    

    Section
3.02                                Authority, Execution and
Delivery.  The Company hereby represents and warrants that the
Company has full corporate power and authority to enter into this Warrant and to
issue Shares in accordance with the terms hereof.  The execution,
delivery and performance of this Warrant by the Company have been duly and
effectively authorized by the Company.  This Warrant has been duly
executed and delivered by the Company and constitutes the legal, valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms.

     

    

    ARTICLE
IV

    CERTAIN
DEFINITIONS

    

    The
following terms, as used in this Warrant, have the following respective
meanings:

    

    "Business Days" means
each day in which banking institutions in New York are not required or
authorized by law or executive order to close.

    

    "Exercise Price" means
$1.50 per share, subject to adjustment pursuant to Article V.

    

    “Fair Market Value”
means the value of a share of Common Stock on a particular date, determined as
follows: (i) if the Common Stock is not listed on such date on any national
securities exchange but is traded in the over-the-counter market, the closing
"bid" quotations of a share of Common Stock on such date (or if none, on the
most recent date on which there were bid quotations of a share of Common Stock),
as reported on the National Association of Securities Dealers, Inc. Automated
Quotation System, or, if not so reported, as reported by the National Quotation
Bureau, Incorporated, or any other similar service selected by the Board; or
(ii) if the Common Stock is listed on such date on one or more national
securities exchanges, the last reported sale price of a share of Common Stock on
such date as recorded on the composite tape system, or, if such system does not
cover the Common Stock, the last reported sale price of a share of Common Stock
on such date on the principal national securities exchange on which the Common
Stock is listed, or if no sale of Common Stock took place on such date, the last
reported sale price of a share of Common Stock on the most recent day on which a
sale of a share of Common Stock took place as recorded by such system or on such
exchange, as the case may be; or (iii) if the Common Stock is neither listed on
such date on a national securities exchange nor traded in the over-the-counter
market, as determined by the Company.

     

    

    ARTICLE
V

    ADJUSTMENTS

     

    Section
5.01                                Adjustment of Warrant
Exercise Price upon Subdivision or Combination of Common
Stock.  If the Company at any time after the date of issuance
of this Warrant subdivides (by any stock split, stock dividend, recapitalization
or otherwise) one or more classes of its outstanding shares of Common Stock into
a greater number of shares, any Warrant Exercise Price in effect immediately
prior to such subdivision will be proportionately reduced and the number of
shares of Common Stock obtainable upon exercise of this Warrant will
be

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    proportionately
increased.  If the Company at any time after the date of issuance of
this Warrant combines (by combination, reverse stock split or otherwise) one or
more classes of its outstanding shares of Common Stock into a smaller number of
shares, any Warrant Exercise Price in effect immediately prior to such
combination will be proportionately increased and the number of Warrant Shares
issuable upon exercise of this Warrant will be proportionately
decreased.  Any adjustment under this Section 5.01 shall become
effective at the close of business on the date the subdivision or combination
becomes effective.

     

     

    Section
5.02                                Notices.  Immediately
upon any adjustment of the Warrant Exercise Price, the Company will give written
notice thereof to the holder of this Warrant, setting forth in reasonable
detail, and certifying, the calculation of such adjustment.

     

    

    ARTICLE
VI

    MISCELLANEOUS

    

    Section
6.01                                Notices.  Any
notice or other communication to be given hereunder shall be in writing and
shall be delivered by recognized courier, telecopy or certified mail, return
receipt requested, and shall be conclusively deemed to have been received by a
party hereto and to be effective on the day on which delivered or telecopied to
such party at its address set forth below (or at such other address as such
party shall specify to the other parties hereto in writing), or, if sent by
certified mail, on the third business day after the day on which mailed,
addressed to such party at such address.  In the case of the Holder,
such notices and communications shall be addressed to its address as shown on
the books maintained by the Warrant Agency, unless the Holder shall notify the
Company and the Warrant Agency that notices and communications should be sent to
a different address, in which case such notices and communications shall be sent
to the address specified by the Holder, and in either case a copy of such
notices and communications shall be sent to Thomas P. Gallagher, Gallagher,
Briody & Butler, 155 Village Boulevard, Princeton, New Jersey 08540 Fax:
(609) 454-0090.  In the case of the Company, such notices and
communications shall be addressed as follows (until notice of a change is given
as provided herein): Performance Health Technologies, Inc., 427 River View
Plaza, Trenton, New Jersey 08611, Attention:  Robert Prunetti,
Fax:  (609) 656-0869.

    

    Section
6.02                                Waivers;
Amendments.  No failure or delay of the Holder in exercising
any power or right hereunder shall operate as a waiver thereof, nor shall any
single or partial exercise of such right or power, or any abandonment or
discontinuance of steps to enforce such a right or power, preclude any other or
further exercise thereof or the exercise of any other right or
power.  The rights and remedies of the Holder are cumulative and not
exclusive of any rights or remedies which it would otherwise
have.  The provisions of this Warrant may be amended, modified or
waived with (and only with) the written consent of the Company and Holders
holding a majority of Warrants at the time outstanding (or any permitted
transferee of all of the Warrant).  In the event of any such
amendment, modification or waiver the Company shall give prompt notice thereof
to all Holders of Warrants and, if appropriate, notation thereof shall be made
on all Warrants thereafter surrendered for registration of transfer or
exchange.  No notice or demand on the Company in any case shall
entitle the Company to any other or further notice or demand in similar or other
circumstances.

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    Section
6.03                                Governing
Law.  This Warrant shall be construed in accordance with and
governed by the laws of the State of Delaware without regard to choice of law
doctrine.

    

    Section
6.04                                Covenants To Bind Successor
and Assigns.  All covenants, stipulations, promises and
agreements in this Warrant contained by or on behalf of the Company shall bind
its successors and assigns, whether so expressed or not.

    

    Section
6.05                                Severability.  In
case any one or more of the provisions contained in this Warrant shall be
invalid, illegal or unenforceable in any respect, the validity, legality and
enforceability of the remaining provisions contained herein and therein shall
not in any way be affected or impaired thereby.  The parties shall
endeavor in good faith negotiations to replace the invalid, illegal or
unenforceable provisions with valid provisions the economic effect of which
comes as close as possible to that of the invalid, illegal or unenforceable
provisions.

    

    Section
6.06                                Section
Headings.  The section headings used herein are for convenience
of reference only, are not part of this Warrant and are not to affect the
construction of or be taken into consideration in interpreting this
Warrant.

    

    Section
6.07                                No Rights as
Stockholder.  This Warrant shall not entitle the Holder to any
rights as a stockholder of the Company.

    

    Section
6.08                                No Requirement to
Exercise.  Nothing contained in this Warrant shall be construed
as requiring the Holder to exercise this Warrant.

    

    IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed in its corporate name by one of its officers
thereunto duly authorized, and attested by its Secretary or an Assistant
Secretary, all as of the day and year first above written.

     

     

    
      
        	 	PERFORMANCE HEALTH
      TECHNOLOGIES, INC.	 
	 	 	 	 
	
                 

              	
                By:
      

              	 	 
	 	 	Name: 	 
	 	 	Title: 	 
	 	 	 	 

      

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

    

    SUBSCRIPTION
NOTICE

    (To be
executed upon exercise of Warrant)

    

    To:  Performance
Health Technologies, Inc. (the "Company")

    

    The
undersigned hereby irrevocably elects:

    

    (i)           to
exercise the right of purchase represented by the attached Warrant for, and to
purchase thereunder, __________ Shares, as provided for therein, and tenders
herewith payment of the Exercise Price in full in the form of certified or bank
cashier's check or wire transfer; or

    

    (ii)           the
"cashless exercise" of its rights under the Section 1.01 of the attached Warrant
with respect to ___________ Shares otherwise available for purchase to it under
the Warrant and receive such number of Shares as provided in the formula set
forth in such Section 1.01.

    

    Please
issue a certificate or certificates for such Shares in the following name or
names and denominations:

    

    

       

        
          

        

      

       

      
        

      

    

    In
connection with the exercise of the Warrant, the undersigned hereby represents
and warrants that:

    

    (i)           it
recognizes that the Shares issuable pursuant to the attached Warrant have not
been registered under the Securities Act and may not be sold, pledged or
otherwise transferred except pursuant to the exceptions set forth on the legend
on such Shares which is also set forth in Section 1.04 of the attached
Warrant;

    

    (ii)           it
has received all material information with respect to the Company which it deems
necessary with its decision to exercise the attached Warrant and it has been
given an opportunity to ask questions and receive answers from representatives
of the Company;

    

    (iii)           it
is purchasing the Shares for its own account, for the purpose of investment
only, and not with a view towards the further resale or distribution thereof;
and

    

    (iv)           it
is an "Accredited Investor" within the meaning of Rule 501 of Regulation D under
the Securities Act of 1933, as amended.

    

    If said
number of Shares shall not be all the Shares issuable upon exercise of the
attached Warrant, a new Warrant is to be issued in the name of the undersigned
for the balance remaining of such Shares less any fraction of a Share paid in
cash.

     

     By:
______________________

     Name:
____________________

     Its:
______________________

     Dated: 
___________________

     

    

     NOTE:     The
above signatory should correspond exactly with the name on the face of the
attached Warrant or with the name of the assignee appearing in the assignment
form below.

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    ASSIGNMENT

    

    (To be
executed upon assignment of Warrant)

     

    

    For value
received and in accordance with Section 2.03 of the attached Warrant,
____________________ hereby sells, assigns and transfers unto
___________________________ the attached Warrant, together with all right, title
and interest therein, and does hereby irrevocably constitute and appoint
__________________ attorney to transfer said Warrant on the books of Performance
Health Technologies, Inc. with full power of substitution in the
premises.

    

     

    By:
___________________________

    Name:
_________________________

    Its:
___________________________

     

    Dated:____________________

    

    
      	
               
      

            	
              NOTE:

            	
              The
      above signatory should correspond exactly with the name on the face of the
      attached Warrant.

            

    

    

    Consented
to and approved in accordance with

    Section
2.03 of the attached Warrant

     

     

    
      
        	

                PERFORMANCE
      HEALTH TECHNOLOGIES, INC.

              	 
	 	 	 
	
                By:
      

              	 	 
	 	Name: 	 
	 	Its: 	 
	 	 	 

      

    

    
 

     

    
      
         

      

      
        10WWW.EXFILE.COM, INC. -- 888-775-4789 -- PERFORMANCE HEALTH TECHNOLOGIES, INC. -- EXHIBIT 10.115 TO FORM 10-KSB

    
      EXHIBIT
10.115

      

      SUBSCRIPTION
AGREEMENT

      

      This
Subscription Agreement (the “Agreement”) is made and entered into as of the date
set forth below by and between the person or entity set forth on the signature
page below (the “Investor”) and Performance Health Technologies, Inc.
(“PHT”).

       

      Recitals

       

      

      WHEREAS, PHT has authorized
the issuance and sale of a note in the principal amount of $50,000 (the “Note”);
and

      

      WHEREAS, the Investor desires
to purchase the Note on the terms set forth herein;

       

      NOW, THEREFORE, in
consideration of the covenants, promises and representations set forth herein
and for other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereby agree as follows:

       

      1.           Purchase
and Sale of Note

       

      1.1   At the
Closing (as defined below) the Investor shall purchase from PHT and PHT shall
sell to the Investor, subject to all of the terms and conditions hereof, the
Note.

      

      1.2   The Note
shall mature in 30 days or upon the closing of the next PHT financing in the
amount of at least $50,000, which ever event comes first.

      

      2.           Closing

      

      2.1           Date of
Closing.  The closing (the “Closing”) of the purchase and sale of
the Note shall take place on any date agreed to by the Investor and PHT (the
“Closing Date”).

      

      2.2           Items to be Delivered by the
Investor to PHT.  The following shall be delivered by the Investor
to PHT on the Closing Date:

      

       

      
        
          	
                   
      

                	
                  (a)

                	
                  this
      Agreement executed by the
Investor;

                

        

      

      

      
        	
                 
      

              	
                (b)

              	
                the
      Investor Questionnaire;

              

      

      

      
        	
                 
      

              	
                (c)

              	
                the
      purchase price for the Note by wire transfer to the following
      account:

              

      

       

      Performance
Health Technologies, Inc.

      Atlantic
Central Bankers Bank:  Camp Hill, PA

      ABA#
031301752

      Account#
220146

      Further Credit
To:

      Hopewell
Valley Community Bank

      ABA#
031207827

      Final Credit
To:

      Performance
Health Technologies, Inc.

      Account#  2000024756

      

      
        
           

        

        
          1

          
            

          

        

        
           

        

      

      2.3           Items to be Delivered to the
Investor by PHT.  The following shall be delivered by PHT to the
Investor on the Closing Date:

      

      
        	
                 
      

              	
                (a)

              	
                the
      Note.  

              

      

      

      3.           Representations
and Warranties of PHT

       

      PHT
hereby represents and warrants to the Investor as follows:

       

      3.1           Corporate Existence and
Power.  PHT is a corporation duly incorporated, validly
existing and in good standing under the laws of the State of
Delaware.  PHT has all corporate power and all material governmental
permits required to carry on its business as now conducted.

      

      3.2           Corporate Authorization;
Enforceability.  The execution, delivery and performance by PHT
of this Agreement and the Note is within PHT’s corporate powers and have been
duly authorized by the Board of Directors of PHT and no other corporate action
on the part of PHT is necessary to authorize this Agreement or issuance of the
Note.  This Agreement has been, and the Note will be, duly executed
and delivered by PHT.  This Agreement constitutes the valid and
binding agreement of PHT, enforceable against PHT in accordance with its terms,
except to the extent that its enforceability may be subject to applicable
bankruptcy, insolvency, reorganization, moratorium and similar laws affecting
the enforcement of creditors’ rights generally and by general principles of
equity.

      

      3.3        
 Capitalization. The
authorized capital stock of PHT consists of 500,000,000 shares of Common Stock
and 100,000,000 shares of Preferred Stock, $0.01 par value per share (“Preferred
Stock”), of which 53,755,697 shares of Common Stock
and no shares of Preferred Stock were issued and outstanding as of March 1,
2008.  All of such outstanding shares have been validly issued and are
fully paid and nonassessable.

      

      3.4           No
Conflict.  The execution, delivery and performance by PHT of
this Agreement, and the consummation of the transactions contemplated hereby,
including issuance of the Note, do not and will not at the Closing, (a) violate
any provision of law, statute, rule or regulation, or any ruling, writ,
injunction, order, judgment or decree of any court, administrative agency or
other governmental body applicable to PHT, or any of its properties or assets,
(b) conflict with or result in any breach of any of the terms, conditions or
provisions of, or constitute (with due notice or lapse of time, or both) a
default (or give rise to any right of termination, cancellation or acceleration)
under, or result in the creation of any encumbrance upon any of the properties
or assets of PHT under any material contract to which PHT is a party or (c)
violate any organizational document of PHT.

       

      3.5           Note.  The
Note, when issued and delivered in accordance with the terms of this Agreement,
will be duly authorized, validly issued, fully paid, non-assessable and free and
clear of any lien or other limitation or restriction.

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

      4.           Representations
and Warranties of the Investor

       

      The
Investor hereby represents and warrants to PHT as follows:

       

      4.1           Organization and Good
Standing; Power and Authority. Any Investor that is a corporation (a) is
a corporation duly organized, validly existing and in good standing under the
laws of its organization, and (b) has all requisite corporate power and
authority and all authorizations, licenses and material permits necessary to
own, lease and operate its properties, to carry on its business as presently
conducted and as proposed to be conducted and to enter into and carry out the
transactions contemplated by this Agreement.

       

      4.2           Authorization of the
Agreement.  This Agreement constitutes a valid and legally
binding obligation of the Investor except to the extent that enforceability may
be limited by bankruptcy, insolvency or similar laws affecting creditors’ rights
generally or by general principles of equity.

       

      4.3           No Conflict. The
execution, delivery and performance by the Investor of this Agreement and the
consummation by the Investor of the transactions contemplated hereby do not and
will not at the Closing (a) violate any provision of law, statute, rule or
regulation, or any ruling, writ, injunction, order, judgment or decree of any
court, administrative agency or other governmental body applicable to the
Investor, or any of its properties or assets, (b) conflict with or result in any
breach of any of the terms, conditions or provisions of, or constitute (with due
notice or lapse of time, or both) a default (or give rise to any right of
termination, cancellation or acceleration) under, or result in the creation of
any encumbrance upon any of the properties or assets of the Investor under any
material contract to which the Investor is a party or (c) violate any
organizational document of any corporate Investor.

       

      4.4           Investment
Representation.

       

      
        	
                 
      

              	
                (a)

              	
                The
      Investor has received and reviewed the following (the “PHT
      Documents”):

              

      

      

      
        	
                1.  

              	
                Subscription
      Agreement;

              

      

      
        	
                2.  

              	
                The
      Note; and

              

      

      
        	
                3.  

              	
                PHT’s
      Form 10-SB and all amendments thereto, PHT’s Form 10-QSBs for the quarters
      ended June 30, 2007 and September 30, 2007 and PHT’s Form 8-Ks filed since
      July 13, 2007.

              

      

      

      
        	
                 
      

              	
                (b)

              	
                The
      Investor or Investor’s designated representatives have concluded a
      satisfactory due diligence investigation of PHT and have had an
      opportunity to review the PHT Documents and to have all of their questions
      related thereto satisfactorily
answered.

              

      

      

      
        	
                 
      

              	
                (c)

              	
                The
      Investor acknowledges that the Note is speculative and involves a high
      degree of risk and the Investor represents that it is able to sustain the
      loss of the entire amount of its
investment.

              

      

      

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

      
        	
                 
      

              	
                (d)

              	
                The
      Investor (or its members and/or officers) has previously invested in
      unregistered securities and has sufficient financial and investing
      expertise to evaluate and understand the risks of the
  Note.

              

      

      

      
        	
                 
      

              	
                (e)

              	
                The
      Investor has received from PHT, and is relying on, no representations or
      projections with respect to PHT’s business and prospects except as set
      forth in this Agreement and the PHT
Documents.

              

      

      

      
        	
                 
      

              	
                (f)

              	
                The
      Investor is an “accredited investor” within the meaning of Regulation D
      under the Securities Act.

              

      

      

      
        	
                 
      

              	
                (g)

              	
                The
      Investor is acquiring the Note for investment purposes only without intent
      to distribute the same, and acknowledges that the Note has not been
      registered under the Securities Act and applicable state securities laws,
      and accordingly, constitutes “restricted securities” for purposes of the
      Securities Act and such state securities
laws.

              

      

      

      
        	
                 
      

              	
                (h)

              	
                The
      Investor acknowledges that it will not be able to transfer the Note except
      upon compliance with the registration requirements of the Securities Act
      and applicable state securities laws or exemptions
    therefrom.

              

      

       

      
        	
                 
      

              	
                (i)

              	
                      
                  The
      certificates and/or instruments evidencing the Note will contain the
      following legend:

                

              

         

      

       

      “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED,
PLEDGED, ASSIGNED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, OR AN EXEMPTION FROM
REGISTRATION AND OTHERWISE IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN
THE ISSUER AND THE ORIGINAL OWNER OF THE SECURITIES, A COPY OF WHICH IS ON FILE
AT THE PRINCIPAL EXECUTIVE OFFICE OF THE ISSUER.”

      

      5.           Miscellaneous

       

      5.1           Definitions.

      

       “Business Day” means a
day that is not a Saturday, Sunday or a day on which commercial banking
institutions located in New York City, New York are authorized or required to
close.

      

      “Securities Act” means
the Securities Act of 1933, as amended.

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

      5.2           Confidentiality.

      

      
        	
                 
      

              	
                (a)

              	
                The
      Investor agrees to keep confidential any and all non-public information
      delivered or made available to the Investor by PHT except
    for

              

      

       disclosures,
as necessary, made by the Investor to the Investor’s officers, directors,
employees, agents, counsel and accountants each of whom shall be notified by the
Investor of this confidentiality covenant and for whom the Investor shall be
liable in the event of any breach of this covenant by any such individual or
individuals; provided, however, that nothing herein shall prevent the Investor
from disclosing such information (i) upon the order of any court or
administrative agency, (ii) upon the request or demand of any regulatory agency
or authority having jurisdiction over the Investor, (iii) which has been
publicly disclosed or (iv) to any of its members provided that any such members
agree in writing (with a copy provided to PHT) to be bound by confidentiality
provisions in form and substance substantially as are contained
herein.  In the event of a mandatory disclosure as described in clause
(i) and/or (ii) of the preceding sentence, the Investor shall promptly notify
PHT in writing of any applicable order, request or demand for such information,
cooperate with PHT if and to the extent that PHT elects to seek an appropriate
protective order or other relief from such order, request, or demand, and
disclose only the minimal amount of information ultimately required to be
disclosed.  No Investor shall use for its own benefit, nor permit any
other person to use for such person’s benefit, any of PHT’s non-public
information including, without limitation, in connection with the purchase
and/or sale of PHT’s securities.

      

      
        	
                 
      

              	
                (b)

              	
                PHT
      shall in no event disclose non-public information to the Investor,
      advisors to or representatives of the Investor unless prior to disclosure
      of such information PHT marks such information as “Non-Public Information
      - Confidential” and provides the Investor, such advisors and
      representatives with the opportunity to accept or refuse to accept such
      non-public information for review.  PHT may, as a condition to
      disclosing any non-public information hereunder, require the Investor’s
      advisors and representatives to enter into a confidentiality agreement in
      form reasonably satisfactory to PHT and the
  Investor.

              

      

      

      
        	
                 
      

              	
                (c)

              	
                Nothing
      herein shall require PHT to disclose non-public information to the
      Investor or its advisors or representatives, and PHT represents that it
      does not disseminate non-public information to any Investors who purchase
      stock in PHT in a public offering, to money managers or to securities
      analysts.

              

      

       

      

      5.3           Costs and
Expenses.  PHT and the Investor shall bear their own costs and
expenses in connection with this transaction.

      
        
           

        

        
          5

          
            

          

        

        
           

        

      

      5.4           Survival.  All
agreements, covenants, representations and warranties made by PHT or by the
Investor herein shall survive the execution and delivery of this
Agreement.

      

      5.5           Notices.  Except
as otherwise provided herein, all notices, requests, demands, consents,
instructions or other communications to or upon PHT, or the Investor under this
Agreement shall be in writing and facsimiled, mailed or delivered to each party
at the facsimile number or its address as provided below (or to such other
facsimile number or address as the recipient of any notice shall have notified
the other in writing).  All such notices and communications shall be
effective (a) when sent by Federal Express or other overnight service of
recognized standing, on the Business Day following the deposit with such
service; (b) when mailed, by registered or certified mail, first class postage
prepaid and addressed as aforesaid through the United States Postal Service,
upon receipt; (c) when delivered by hand, upon delivery; and (d) when
facsimiled, upon confirmation of receipt to the following:

      

      Performance
Health Technologies, Inc.

      427 River
View Plaza, Trenton, New Jersey 08611

      Attention:  Robert
Prunetti

      Fax:  (609)
656-0869

      

      To the
Investor at the Address Set Forth on the Investor Questionnaire attached
hereto.

       

      

      5.6           Nonwaiver.  No
failure or delay on any party in exercising any right hereunder shall operate as
a waiver thereof or of any other right nor shall any single or partial exercise
of any such right preclude any other further exercise thereof or of any other
right.

      

      5.7           Amendments and
Waivers.  This Agreement may not be amended or modified, nor
may any of its terms be waived, except by written instruments signed by all of
the parties.  Such waiver or consent under any provision hereof shall
be effective only in the specific instances for the purpose for which
given.

      

      5.8           Assignments.  This
Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective successors and assigns.

      

      5.9           Partial
Invalidity.  If at any time any provision of this Agreement is
or becomes illegal, invalid or unenforceable in any respect under the law of any
jurisdiction, neither the legality, validity or enforceability of the remaining
provisions of this Agreement nor the legality, validity or enforceability of
such provision under the law of any other jurisdiction shall in any way be
affected or impaired thereby.

      

      5.10           Headings.  Headings
in this Agreement are for convenience of reference only and are not part of the
substance hereof or thereof.

      

      5.11           Entire
Agreement.  This Agreement constitutes and contains the entire
agreement of the parties hereto and supersedes any and all prior agreements,
negotiations, correspondence, understandings and communications among the
parties, whether written or oral, respecting the subject matter
hereof.

      

      5.12           Governing
Law.  This Agreement shall be governed by and construed in
accordance with the laws of the State of  New Jersey without reference
to conflicts of law rules.

      
        
           

        

        
          6

          
            

          

        

        
           

        

      

      5.13           Jurisdiction.  Any
suit, action or proceeding seeking to enforce any provision of, or based on any
matter arising out of or in connection with, this Agreement or the transactions
contemplated hereby may be brought in the courts of the State of New Jersey
located in the County of Mercer and the federal courts of the United States of
America located in such State and County.  Each of the parties (a)
consents to the exclusive jurisdiction of such courts (and of the appropriate
appellate courts therefrom) in any such suit, action or proceeding, (b)
irrevocably waives, to the fullest extent permitted by law, any objection which
it may now or hereafter have to the laying of the venue of any such suit, action
or proceeding in any such court or that any such suit, action or proceeding
which is brought in any such court has been brought in an inconvenient forum,
(c) will not attempt to deny or defeat such personal jurisdiction by motion or
other request for leave from any such court, and (d) will not bring any
action relating to this Agreement or any of the transactions contemplated by
this Agreement in any other court.  Process in any such suit, action
or proceeding may be served on any party anywhere in the world, whether within
or without the jurisdiction of any such court.  Without limiting the
foregoing, each party agrees that service of process on such party as provided
in Section 6.6 will be deemed effective service of process on such
party.

      

      5.14           JURY
TRIAL.  EACH
PARTY HERETO, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY
IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY
ISSUE.

      

      5.15           Counterparts.  This
Agreement may be executed in several counterparts, each of which shall be deemed
an original, but such counterparts shall together constitute but one and the
same agreement.

      

      * *
*

      

      
        
           

        

        
          7

          
            

          

        

        
           

        

      

      IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date set
forth below.

      

       

      
        
          	 	      
                  INVESTOR:

                	 
	 	 	 	 
	
                  Date:
      March ____, 2007

                	
                  By:
      

                	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

        

      

       

      
        
          
            	 	PERFORMANCE
      HEALTH TECHNOLOGIES, INC.	 
	 	 	 	 
	
                    Date:
      March ____, 2007

                  	
                    By:
      

                  	 	 
	 	 	Robert
      D. Prunetti 	 
	 	 	President
      and Chief Executive Officer 	 
	 	 	 	 

          

        

      

       

      

       

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

      A.          
 INDIVIDUALS (If Investor is an individual, complete this Part
A)

      

      1.            
Name of Investor(s)1 
_________________________________________                                                  

      
 

      Address
(including Zip
Code)  __________________________________                                                              

      
 

      Telephone
No.    (         )  ____________________                                                    

      Telecopy
No.      (         )  ____________________                                                    

      

      2.           Indicate
type of ownership subscribed for:

       

      Individual

      Joint
Tenants with Rights of Survivorship

      Tenant in
Common

      Tenants
by the Entirety

      

      3.           Social
Security Number(s)
_________________________                                                                

      

      4.           Each
Investor must initial at least one of the following statements:

      

      
        	
                 
      

              	
                ____

              	
                (a)

              	
                Investor
      certifies that he/she is a director or executive officer of
      PHT.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (b)

              	
                Investor
      certifies that he/she is a natural person whose individual net worth, or
      joint net worth with his/her spouse, at the time of his/her Loan to PHT
      exceed $1,000,000 (inclusive of the value of his/her home, home
      furnishings and automobiles).

              

      

      

      
        	
                 
      

              	
                ____

              	
                (c)

              	
                Investor
      certifies that he/she is a natural person who has an individual
      income2 in excess of $200,000 in each of the two
      most recent years or joint income with his/her spouse in excess of
      $300,000 in each of those years, and has a reasonable expectation of
      reaching the same income level in the current
  year.

              

      

      

        

      

       

        
          	
                  1

                	
                  If
      there is more than one Investor other than husband and wife, a separate
      Investor Questionnaire must be completed for each such Investor and
      attached to this Investor Questionnaire.  If Investors are
      husband and wife, please include both names, be certain to complete item 2
      and include both social security numbers (indicating to which individual
      each social security number belongs) in item
3.

                

        

      

       

        
          	
                  2

                	
                  In
      determining income, a Investor should add to his or her adjusted gross
      income any amounts attributable to tax-exempt income received, losses
      claimed as a limited partner in any limited partnership, deductions
      claimed for depletion, contributions to IRA or Keogh retirement plans,
      alimony payments and any amount by which income from long-term capital
      gains has been reduced in arriving at adjusted gross
    income.

                

        

      

      
        
           

        

        
          9

          
            

          

        

        
           

        

      

      B.        
   ENTITIES (If Investor is an entity, complete this Part
B)

      
1.        
    Name of Investor 
_________________________________________                                                                                                                               

      
 

      Address
(including Zip
Code) ________________________________                                                               

      
 

      Telephone
No.      (        )   _____________________                                                   

      Telecopy
No.        (         )  _____________________                                                    

      

      2.           
 Indicate type of entity:

      

      ____       Corporation                   ____       Trust         ____    
 Limited Partnership

      

      ____       General
Partnership      ____       IRA           ____   
  Pension Plan or Trust

      

      Other:  _________________________________________________________                    

      

      3.            
Date of formation or
incorporation:   ___________________________________                                                                        

      

      4.          
  State of formation or
incorporation:  ___________________________________

       

      
        5.            
Indicate
whether Investor was organized for the specific purpose of acquiring the
securities of PHT.

         

      

                     
Yes ____    No ____

      

      6.         
  Indicate the individual(s) authorized to execute documents on behalf
of the Entity Investor in connection with this investment:

       

      
                      
Name: _______________________________________

      

      
                      
Title: ________________________________________

      

      

      
                      
Taxpayer Identification Number: 

      

      

      
        7.           
Each
Investor must initial at least one of the following
statements:

      

      

      
        	
                 
      

              	
                ____

              	
                (a)

              	
                Investor
      certifies that it is a bank as defined in Section 3(a)(2) of the
      Securities Act of 1933, as amended (the “Act”), or any savings and loan
      association or other institution as defined in Section 3(a)(5)(A) of the
      Act, whether acting in its individual or fiduciary
    capacity.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (b)

              	
                Investor
      certifies that it is an insurance company as defined in Section 2(13) of
      the Act.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (c)

              	
                Investor
      certifies that it is a broker/dealer registered pursuant to the Securities
      Exchange Act of 1934, as amended.

              

      

      

      
        
           

        

        
          10

          
            

          

        

        
           

        

      

      
        	
                 
      

              	
                ____

              	
                (d)

              	
                Investor
      certifies that it is an investment company registered under the Investment
      Company Act of 1940, as amended, or business development company as
      defined in Section 2(a)(48) of such
Act.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (e)

              	
                Investor
      certifies that it is a Small Business Investment Company licensed by the
      U.S. Small Business Administration under Section 301(c) or (d) of the
      Small Business Investment Act of
1958.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (f)

              	
                Investor
      certifies that it is an employee benefit plan within the meaning of Title
      I of the Employee Retirement Income Security Act of 1974, as amended
      (“ERISA”), and either (i) the investment decision is made by a plan
      fiduciary, as defined in Section 3(21) of ERISA, which is either a bank,
      savings and loan association, insurance company or registered investment
      adviser, (ii) the employee benefit plan has total assets in excess of
      $5,000,000, or (iii) if a self-directed plan, investment decisions are
      made solely by persons that are “accredited investors” as defined in Rule
      501(a) of Regulation D promulgated under the
  Act.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (g)

              	
                Investor
      certifies that it is a private business development company as defined in
      Section 202(a)(22) of the Investment Advisers Act of 1940, as
      amended.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (h)

              	
                Investor
      certifies that it is a corporation, partnership, a Massachusetts or
      similar business trust or other trust (if the trust’s purchase of
      securities is directed by a sophisticated person as described in Rule
      506(b)(2)(ii) of Regulation D under the Act) or other organization
      described in Section 501(c)(3) of the Internal Revenue Code of 1986, as
      amended, not formed for the specific purpose of acquiring the securities
      of PHT, with total assets in excess of
  $5,000,000.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (i)

              	
                Investor
      certifies that it is an entity in which all of the equity owners are
      “accredited investors” as defined in Rule 501(a) of Regulation D
      promulgated under the Act.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (j)

              	
                None
      of the statements in clauses (a) through (i) are applicable to the Entity
      Investor and the Entity Investor is otherwise not an “accredited investor”
      as defined in Rule 501(a) of Regulation D promulgated under the
      Act.

              

      

      

      
        	
                8.

              	
                Investor
      agrees to provide, upon request by PHT, the following
      information:

              

      

      

      
        	
                 
      

              	
                (A)

              	
                Corporations
      will provide the articles of incorporation, by-laws and corporate
      resolution authorizing the Loan and authorizing the person(s) signing this
      Investor Questionnaire.  All the documents must be certified by
      the Secretary or Assistant Secretary of the corporation as being true and
      correct copies thereof and in full force and
  effect.

              

      

      

      
        
           

        

        
          11

          
            

          

        

        
           

        

      

      
        	
                 
      

              	
                (B)

              	
                Partnerships
      and limited liability companies will provide a copy of the partnership
      agreement, articles of organization, and/or operating agreement showing
      the date of formation and giving evidence of the authority of the
      person(s) signing this Investor
Questionnaire.

              

      

      

      
        	
                 
      

              	
                (C)

              	
                Trusts
      will provide a copy of the trust agreement showing the date of formation
      and giving evidence of the authority of the person(s) signing this
      Investor Questionnaire.

              

      

      

      
        C.           
ACKNOWLEDGEMENTS
AND REPRESENTATIONS TO BE MADE BY ALL INVESTORS (Every Investor must complete
this Part C)

      

      

      Investor
understands that PHT will be relying on the accuracy and completeness of the
representations made above as well as Investor’s responses to the questions
contained in this Investor Questionnaire.  Investor understands that a
false representation may constitute a violation of law, and that any person who
suffers damage as a result of a false representation may have a claim for
damages as a result of such false representation.

      

      ALL
INFORMATION CONTAINED IN THIS QUESTIONNAIRE WILL BE TREATED
CONFIDENTIALLY.  However, Investor agrees that PHT may present this
Investor Questionnaire to such parties as PHT deems appropriate if called upon
to establish that the Loan is exempt from registration under the Securities Act
of 1933, as amended, or meets the requirements of applicable state securities
law.

      

      Investor
represents and warrants to PHT as follows (each Investor must initial all of the
following):

      

      
        	
                 
      

              	
                ____

              	
                (a)

              	
                The
      representations and the answers to the questions in this Investor
      Questionnaire are complete and correct and may be relied upon by PHT and
      its counsel.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (b)

              	
                Investor
      has full power and authority to make the Loan to
  PHT.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (c)

              	
                The
      Loan and this Investor Questionnaire have been duly and validly
      authorized, executed, and delivered by Investor and constitute the valid,
      binding, and enforceable agreement of
Investor.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (d)

              	
                Investor
      has reviewed this Questionnaire, including, but not limited to the
      information set forth on pages 1-2, the Cover Letter accompanying this
      Subscription Agreement, the Note and has received all information Investor
      has deemed relevant and has had all of Investor’s questions answered with
      respect to the Loan and PHT and has made such independent investigation
      into PHT as Investor has deemed
necessary.

              

      

      

      
        
           

        

        
          12

          
            

          

        

        
           

        

      

      
        	
                 
      

              	
                ____

              	
                (e)

              	
                The
      Loan is made solely for the account of Investor with a view to and for
      investment and not with a view to or for distribution, assignment,
      participation, or resale.  Investor has no contract,
      undertaking, agreement, or arrangement with any person to sell, transfer,
      or pledge the Note, the Loan, or any interest therein.  There
      are substantial restrictions on the transferability of the
      Note.  There will be no public market for the Note and Investor
      must bear the economic risk involved in the Loan for an indefinite
      term.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (f)

              	
                Investor
      acknowledges there is a substantial economic risk with respect to the
      repayment of the Loan or any interest therein and that Investor has such
      knowledge and experience in financial and business matters that Investor
      is able to evaluate the risks and merits of the Loan and is making an
      informed decision to make the Loan.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (g)

              	
                Investor
      did not learn about the Loan through any advertisement, article, notice,
      or other communication published in any newspaper, magazine, or similar
      media or broadcast over television, radio, or the internet or at any
      seminar or meeting to which Investor was invited by a general solicitation
      or advertising.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (h)

              	
                Investor
      hereby agrees to indemnify PHT and its officers, directors, shareholders,
      agents, and employees and to hold each of such entities and persons
      harmless from and against any and all liabilities, loss, damages, costs,
      or expenses (including reasonable attorneys’ fees) to which they, or any
      of them, may be put or which they, or any of them, may incur by reason of
      any breach of the representations and warranties made by Investor in this
      Investor Questionnaire.

              

      

      

      
        	
                 
      

              	
                ____

              	
                (i)

              	
                Investor
      will notify PHT immediately of any material change in any representation
      made above or any statement made herein that occurs prior to the closing
      of the Loan.

              

      

      

      
         
* *
*

      

      
        
           

        

        
          13

          
            

          

        

        
           

        

      

      If
Investor is an individual:

      

      
        
          	
                   

                	 	 	
                   

                	 
	
                  Signature
      of Investor

                	 	 	
                  Print
      Name of Investor

                	 

        

    

    
      
        	
                 

              	 	 	
                 

              	 
	
                Signature
      of Spouse, if applicable

              	 	 	
                Print
      Name of Spouse, if applicable

              	 
	 	 	 	 	 
	Date:__________________,
      2008 	 	 	 	 

      

    

     

     

    If Investor is an entity:
       

    

    
      
        
          
            	
                     

                  	 	 	
                     

                  	 
	
                    Signature
      of Officer, Trustee or Partner, as applicable

                  	 	 	
                    Print
      Name of Officer, Trustee, or Partner, as applicable

                  	 
	 	 	 	 	 
	Date:__________________,
      2008 	 	 	Date:__________________,
      2008 	 

          

      

      

      
        
          	      
                  PHT
      hereby accepts the Loan from

                  Investor
      as of ______________, 2008

                	 
	 	 
	Performance
      Health Technologies, Inc. 	 
	 	 	 
	
                  By:
      

                	/s/ 	 
	 	Robert
      D. Prunetti	 
	 	 	 
	 	 	 

        

      

      

      

      
        
           

        

        
          14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]